NWAM LLC’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

NWAM LLC’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-43,999	Closed	-$2.25M	–	527
2020 Q4	$2.25M	Sell	43,999 -2,604	-6%	-$124K	0.26%	98
2020 Q3	$1.92M	Sell	46,603 -243	-0.5%	-$10K	0.32%	85
2020 Q2	$1.96M	Sell	46,846 -160	-0.3%	-$6.31K	0.27%	91
2020 Q1	$1.49K	Buy	+47,006	New	+$1.8M	0.04%	116

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

NWAM LLC's SBIO Position: Q1 2021 in Review

NWAM LLC sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2021, closing a stake of 43,999 shares — an estimated $2.25M sold.

NWAM LLC first reported a position in SBIO in Q1 2020 and held it in 4 quarters. The position peaked at $2.25M in Q4 2020. 70 funds tracked by Wall St. Rank hold SBIO as of Q1 2021.

NWAM LLC reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2021 after selling out during the quarter.
NWAM LLC sold 43,999 ALPS Medical Breakthroughs ETF shares in Q1 2021, an estimated $2.25M.
NWAM LLC first reported a position in ALPS Medical Breakthroughs ETF in Q1 2020 and held it in 4 quarters.
NWAM LLC's ALPS Medical Breakthroughs ETF position peaked at $2.25M in Q4 2020.
70 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2021.

Based on NWAM LLC's 13F filing for Q1 2021, filed 23 Apr 2021.